子宫颈原位腺癌诊断与管理的中国专家共识(2021年版)

2021-12-02 中国医师协会妇产科医师分会妇科肿瘤专业委员会 中国实用妇科与产科杂志

随着子宫颈癌、子宫颈病变的规范筛查与诊治,以及人乳头瘤病毒疫苗预防接种的宣教和启动,子宫颈鳞状细胞癌在子宫颈恶性肿瘤所占比例呈下降趋势,而子宫颈腺病变包括原位腺癌的发病比率逐渐增加。

中文标题:

子宫颈原位腺癌诊断与管理的中国专家共识(2021年版)

发布日期:

2021-12-02

简要介绍:

随着子宫颈癌、子宫颈病变的规范筛查与诊治,以及人乳头瘤病毒(human papillomavirus,HPV)疫苗预防接种的宣教和启动,子宫颈鳞状细胞癌在子宫颈恶性肿瘤所占比例呈下降趋势,而子宫颈腺病变包括原位腺癌(adenocarcinoma in situ,AIS)的发病比率逐渐增加。

相关资料下载:
[AttachmentFileName(sort=1, fileName=子宫颈原位腺癌诊断与管理的中国专家共识(2021年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=d70c81c002300811, title=子宫颈原位腺癌诊断与管理的中国专家共识(2021年版), enTitle=, guiderFrom=中国实用妇科与产科杂志, authorId=0, author=, summary=随着子宫颈癌、子宫颈病变的规范筛查与诊治,以及人乳头瘤病毒疫苗预防接种的宣教和启动,子宫颈鳞状细胞癌在子宫颈恶性肿瘤所占比例呈下降趋势,而子宫颈腺病变包括原位腺癌的发病比率逐渐增加。, cover=https://img.medsci.cn/20211224/1640335913380_5579292.png, journalId=0, articlesId=null, associationId=2143, associationName=中国医师协会妇产科医师分会妇科肿瘤专业委员会, associationIntro=中国医师协会妇产科医师分会妇科肿瘤专业委员会(学组), copyright=0, guiderPublishedTime=Thu Dec 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">随着子宫颈癌、子宫颈病变的规范筛查与诊治,以及人乳头瘤病毒(human papillomavirus,HPV)疫苗预防接种的宣教和启动,子宫颈鳞状细胞癌在子宫颈恶性肿瘤所占比例呈下降趋势,而子宫颈腺病变包括原位腺癌(adenocarcinoma in situ,AIS)的发病比率逐渐增加。</span></p>, tagList=[TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=120381, tagName=子宫颈原位腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=120084, guiderKeyword=宫颈原位腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2593, appHits=169, showAppHits=0, pcHits=523, showPcHits=2423, likes=2, shares=35, comments=9, approvalStatus=1, publishedTime=Fri Dec 24 16:48:04 CST 2021, publishedTimeString=2021-12-02, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Dec 24 16:57:04 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Mon Jan 01 19:15:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=子宫颈原位腺癌诊断与管理的中国专家共识(2021年版).pdf)])
子宫颈原位腺癌诊断与管理的中国专家共识(2021年版).pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1235991, encodeId=13f81235991a2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6daa8256824, createdName=ms9000000566772506, createdTime=Mon Aug 01 18:09:27 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189366, encodeId=722b1189366d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:45:09 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184689, encodeId=37f71184689e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Sat Jan 15 22:42:57 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181389, encodeId=79da1181389fe, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:46:48 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085660, encodeId=0f431085660c8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:06:47 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-08-01 ms9000000566772506

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1235991, encodeId=13f81235991a2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6daa8256824, createdName=ms9000000566772506, createdTime=Mon Aug 01 18:09:27 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189366, encodeId=722b1189366d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:45:09 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184689, encodeId=37f71184689e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Sat Jan 15 22:42:57 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181389, encodeId=79da1181389fe, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:46:48 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085660, encodeId=0f431085660c8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:06:47 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-01-30 120c570cm03暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1235991, encodeId=13f81235991a2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6daa8256824, createdName=ms9000000566772506, createdTime=Mon Aug 01 18:09:27 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189366, encodeId=722b1189366d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:45:09 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184689, encodeId=37f71184689e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Sat Jan 15 22:42:57 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181389, encodeId=79da1181389fe, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:46:48 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085660, encodeId=0f431085660c8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:06:47 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-01-15 1e167f5cm82(暂无匿称)

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1235991, encodeId=13f81235991a2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6daa8256824, createdName=ms9000000566772506, createdTime=Mon Aug 01 18:09:27 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189366, encodeId=722b1189366d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:45:09 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184689, encodeId=37f71184689e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Sat Jan 15 22:42:57 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181389, encodeId=79da1181389fe, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:46:48 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085660, encodeId=0f431085660c8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:06:47 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-01-06 ms5000000224637601

    学到了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1235991, encodeId=13f81235991a2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6daa8256824, createdName=ms9000000566772506, createdTime=Mon Aug 01 18:09:27 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189366, encodeId=722b1189366d3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Jan 30 21:45:09 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184689, encodeId=37f71184689e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Sat Jan 15 22:42:57 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181389, encodeId=79da1181389fe, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:46:48 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085660, encodeId=0f431085660c8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:06:47 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2021-12-30 D-House

    学习

    0